JMCR Partners made 3 investments as of 2019. Their most recent investment was on Sep 26, 2019, when Viva Biotech raised CN¥65M. Viva Ventures Biotech Fund leverages 24 scientific GP partners to invest in 0->1 (idea to pre-clinical, first-in-class) drug discovery startups. The fund uses a peer-to-peer review method and selects 12-15 startups from 600+ deals reviewed per year. Viva Ventures targets blockbuster or billion dollar-sales new drug/ distributive innovative biotech startups with a success rate of over 60%, potential 3 X annual return, over 2-3 years investment period.
Viva Biotech is a drug discovery platform focused on preclinical-stage drug development.